nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2D6—Vinorelbine—ovarian cancer	0.169	0.255	CbGbCtD
Chlorzoxazone—CYP3A4—Topotecan—ovarian cancer	0.153	0.23	CbGbCtD
Chlorzoxazone—CYP3A4—Vinorelbine—ovarian cancer	0.108	0.162	CbGbCtD
Chlorzoxazone—CYP3A4—Paclitaxel—ovarian cancer	0.0756	0.114	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—ovarian cancer	0.0641	0.0964	CbGbCtD
Chlorzoxazone—CYP3A4—Docetaxel—ovarian cancer	0.0547	0.0822	CbGbCtD
Chlorzoxazone—CYP3A4—Doxorubicin—ovarian cancer	0.0407	0.0613	CbGbCtD
Chlorzoxazone—Digestion impaired—Chlorambucil—ovarian cancer	0.0162	0.0764	CcSEcCtD
Chlorzoxazone—Digestion impaired—Melphalan—ovarian cancer	0.0141	0.0666	CcSEcCtD
Chlorzoxazone—Dizziness—Altretamine—ovarian cancer	0.0072	0.0339	CcSEcCtD
Chlorzoxazone—Lightheadedness—Paclitaxel—ovarian cancer	0.00497	0.0234	CcSEcCtD
Chlorzoxazone—Angioedema—Chlorambucil—ovarian cancer	0.00433	0.0204	CcSEcCtD
Chlorzoxazone—Lightheadedness—Docetaxel—ovarian cancer	0.00421	0.0198	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Topotecan—ovarian cancer	0.00391	0.0184	CcSEcCtD
Chlorzoxazone—Petechiae—Epirubicin—ovarian cancer	0.00386	0.0182	CcSEcCtD
Chlorzoxazone—Angioedema—Topotecan—ovarian cancer	0.00386	0.0182	CcSEcCtD
Chlorzoxazone—Malaise—Topotecan—ovarian cancer	0.0038	0.0179	CcSEcCtD
Chlorzoxazone—KCNMA1—myometrium—ovarian cancer	0.00358	0.117	CbGeAlD
Chlorzoxazone—Petechiae—Doxorubicin—ovarian cancer	0.00357	0.0168	CcSEcCtD
Chlorzoxazone—Discomfort—Topotecan—ovarian cancer	0.00355	0.0167	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Topotecan—ovarian cancer	0.00344	0.0162	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00342	0.0161	CcSEcCtD
Chlorzoxazone—Dyspepsia—Chlorambucil—ovarian cancer	0.0034	0.016	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Melphalan—ovarian cancer	0.00337	0.0159	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00335	0.0158	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00334	0.0157	CcSEcCtD
Chlorzoxazone—Angioedema—Vinorelbine—ovarian cancer	0.0033	0.0155	CcSEcCtD
Chlorzoxazone—Malaise—Vinorelbine—ovarian cancer	0.00325	0.0153	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Chlorambucil—ovarian cancer	0.00319	0.015	CcSEcCtD
Chlorzoxazone—Discomfort—Vinorelbine—ovarian cancer	0.00304	0.0143	CcSEcCtD
Chlorzoxazone—Dyspepsia—Topotecan—ovarian cancer	0.00303	0.0143	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00297	0.014	CcSEcCtD
Chlorzoxazone—Dyspepsia—Melphalan—ovarian cancer	0.00297	0.014	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00295	0.0139	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00291	0.0137	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—ovarian cancer	0.00287	0.0135	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Topotecan—ovarian cancer	0.00284	0.0134	CcSEcCtD
Chlorzoxazone—KCNMA1—epithelium—ovarian cancer	0.00281	0.0915	CbGeAlD
Chlorzoxazone—Ecchymosis—Doxorubicin—ovarian cancer	0.00266	0.0125	CcSEcCtD
Chlorzoxazone—KCNMA1—decidua—ovarian cancer	0.00266	0.0865	CbGeAlD
Chlorzoxazone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00254	0.012	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Vinorelbine—ovarian cancer	0.00243	0.0114	CcSEcCtD
Chlorzoxazone—KCNMA1—gonad—ovarian cancer	0.00234	0.0761	CbGeAlD
Chlorzoxazone—KCNMA1—uterus—ovarian cancer	0.00232	0.0756	CbGeAlD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.0023	0.0109	CcSEcCtD
Chlorzoxazone—Dizziness—Topotecan—ovarian cancer	0.00228	0.0107	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00225	0.0106	CcSEcCtD
Chlorzoxazone—Angioedema—Paclitaxel—ovarian cancer	0.00222	0.0104	CcSEcCtD
Chlorzoxazone—Malaise—Paclitaxel—ovarian cancer	0.00219	0.0103	CcSEcCtD
Chlorzoxazone—Rash—Topotecan—ovarian cancer	0.00217	0.0102	CcSEcCtD
Chlorzoxazone—Dermatitis—Topotecan—ovarian cancer	0.00217	0.0102	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00213	0.01	CcSEcCtD
Chlorzoxazone—Rash—Melphalan—ovarian cancer	0.00213	0.01	CcSEcCtD
Chlorzoxazone—Dermatitis—Melphalan—ovarian cancer	0.00212	0.01	CcSEcCtD
Chlorzoxazone—KCNMA1—female reproductive system—ovarian cancer	0.00209	0.068	CbGeAlD
Chlorzoxazone—Discomfort—Paclitaxel—ovarian cancer	0.00204	0.00962	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00198	0.00933	CcSEcCtD
Chlorzoxazone—Dizziness—Vinorelbine—ovarian cancer	0.00195	0.00917	CcSEcCtD
Chlorzoxazone—Rash—Vinorelbine—ovarian cancer	0.00186	0.00875	CcSEcCtD
Chlorzoxazone—Dermatitis—Vinorelbine—ovarian cancer	0.00186	0.00874	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—ovarian cancer	0.00178	0.00836	CcSEcCtD
Chlorzoxazone—Somnolence—Paclitaxel—ovarian cancer	0.00176	0.00829	CcSEcCtD
Chlorzoxazone—Dyspepsia—Paclitaxel—ovarian cancer	0.00174	0.00821	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00171	0.00805	CcSEcCtD
Chlorzoxazone—KCNMA1—testis—ovarian cancer	0.00169	0.0549	CbGeAlD
Chlorzoxazone—Anaphylactic shock—Docetaxel—ovarian cancer	0.00168	0.00791	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—ovarian cancer	0.00164	0.00774	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Paclitaxel—ovarian cancer	0.00163	0.00769	CcSEcCtD
Chlorzoxazone—CYP2A6—vagina—ovarian cancer	0.00158	0.0514	CbGeAlD
Chlorzoxazone—Somnolence—Docetaxel—ovarian cancer	0.00149	0.00703	CcSEcCtD
Chlorzoxazone—Dyspepsia—Docetaxel—ovarian cancer	0.00148	0.00696	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00145	0.00683	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Docetaxel—ovarian cancer	0.00138	0.00652	CcSEcCtD
Chlorzoxazone—Dizziness—Paclitaxel—ovarian cancer	0.00131	0.00617	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—ovarian cancer	0.00129	0.00606	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—ovarian cancer	0.00125	0.00589	CcSEcCtD
Chlorzoxazone—Rash—Paclitaxel—ovarian cancer	0.00125	0.00588	CcSEcCtD
Chlorzoxazone—Dermatitis—Paclitaxel—ovarian cancer	0.00125	0.00588	CcSEcCtD
Chlorzoxazone—KCNMA1—lymph node—ovarian cancer	0.00122	0.0398	CbGeAlD
Chlorzoxazone—CYP1A1—epithelium—ovarian cancer	0.00122	0.0396	CbGeAlD
Chlorzoxazone—CYP1A1—uterine cervix—ovarian cancer	0.00121	0.0393	CbGeAlD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00119	0.00561	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—ovarian cancer	0.00117	0.0055	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—ovarian cancer	0.00116	0.00545	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—ovarian cancer	0.00113	0.00533	CcSEcCtD
Chlorzoxazone—Dizziness—Docetaxel—ovarian cancer	0.00111	0.00523	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—ovarian cancer	0.00108	0.00509	CcSEcCtD
Chlorzoxazone—Rash—Docetaxel—ovarian cancer	0.00106	0.00499	CcSEcCtD
Chlorzoxazone—Dermatitis—Docetaxel—ovarian cancer	0.00106	0.00498	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00105	0.00494	CcSEcCtD
Chlorzoxazone—CYP1A1—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00103	0.0112	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.00101	0.0109	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00101	0.0109	CbGpPWpGaD
Chlorzoxazone—Somnolence—Epirubicin—ovarian cancer	0.00101	0.00474	CcSEcCtD
Chlorzoxazone—CYP1A1—uterus—ovarian cancer	0.00101	0.0327	CbGeAlD
Chlorzoxazone—Dyspepsia—Epirubicin—ovarian cancer	0.000997	0.00469	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000978	0.0046	CcSEcCtD
Chlorzoxazone—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.000965	0.0104	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—RAD51C—ovarian cancer	0.000958	0.0104	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Epirubicin—ovarian cancer	0.000933	0.0044	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—ovarian cancer	0.000932	0.00439	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—ovarian cancer	0.000923	0.00434	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000905	0.00426	CcSEcCtD
Chlorzoxazone—CYP1A1—female reproductive system—ovarian cancer	0.000904	0.0294	CbGeAlD
Chlorzoxazone—CYP1A1—Oxidative Stress—SOD1—ovarian cancer	0.000897	0.0097	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000864	0.00407	CcSEcCtD
Chlorzoxazone—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000853	0.00923	CbGpPWpGaD
Chlorzoxazone—CYP2E1—female reproductive system—ovarian cancer	0.000824	0.0268	CbGeAlD
Chlorzoxazone—CYP1A1—female gonad—ovarian cancer	0.000822	0.0268	CbGeAlD
Chlorzoxazone—CYP1A1—vagina—ovarian cancer	0.000817	0.0266	CbGeAlD
Chlorzoxazone—CYP1A1—Oxidative Stress—SOD2—ovarian cancer	0.000807	0.00873	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000795	0.0086	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—ovarian cancer	0.000793	0.00857	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000786	0.00851	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000778	0.00842	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000776	0.00839	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000765	0.00828	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000758	0.0082	CbGpPWpGaD
Chlorzoxazone—Dizziness—Epirubicin—ovarian cancer	0.000749	0.00353	CcSEcCtD
Chlorzoxazone—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000745	0.00806	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000715	0.00773	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000715	0.00773	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.000715	0.00773	CbGpPWpGaD
Chlorzoxazone—Rash—Epirubicin—ovarian cancer	0.000714	0.00336	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—ovarian cancer	0.000714	0.00336	CcSEcCtD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—TYMS—ovarian cancer	0.000706	0.00764	CbGpPWpGaD
Chlorzoxazone—Dizziness—Doxorubicin—ovarian cancer	0.000693	0.00326	CcSEcCtD
Chlorzoxazone—CYP1A1—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.00069	0.00747	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000669	0.00723	CbGpPWpGaD
Chlorzoxazone—CYP2E1—testis—ovarian cancer	0.000665	0.0217	CbGeAlD
Chlorzoxazone—CYP3A4—female reproductive system—ovarian cancer	0.000663	0.0216	CbGeAlD
Chlorzoxazone—Rash—Doxorubicin—ovarian cancer	0.000661	0.00311	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—ovarian cancer	0.00066	0.00311	CcSEcCtD
Chlorzoxazone—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000659	0.00713	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000659	0.00712	CbGpPWpGaD
Chlorzoxazone—CYP2D6—female reproductive system—ovarian cancer	0.000653	0.0212	CbGeAlD
Chlorzoxazone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000642	0.00695	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000629	0.0068	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000613	0.00663	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000605	0.00654	CbGpPWpGaD
Chlorzoxazone—CYP2D6—female gonad—ovarian cancer	0.000594	0.0193	CbGeAlD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000578	0.00625	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00057	0.00617	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000541	0.00585	CbGpPWpGaD
Chlorzoxazone—CYP1A1—lymph node—ovarian cancer	0.000529	0.0172	CbGeAlD
Chlorzoxazone—CYP2D6—testis—ovarian cancer	0.000527	0.0171	CbGeAlD
Chlorzoxazone—KCNMA1—Hemostasis—SPARC—ovarian cancer	0.000512	0.00554	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000497	0.00537	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—YAP1—ovarian cancer	0.000479	0.00518	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000478	0.00517	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—ovarian cancer	0.000469	0.00507	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000468	0.00507	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000456	0.00493	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.000456	0.00493	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000456	0.00493	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000449	0.00485	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.00044	0.00476	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000435	0.0047	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000429	0.00464	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000426	0.00461	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.000411	0.00445	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.000397	0.0043	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000387	0.00419	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—SOD1—ovarian cancer	0.000372	0.00402	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PPP2R1A—ovarian cancer	0.00037	0.004	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000369	0.00399	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000368	0.00399	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000364	0.00393	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000353	0.00381	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000352	0.0038	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—PTEN—ovarian cancer	0.000343	0.00371	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000336	0.00363	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	0.000334	0.00361	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	0.000323	0.0035	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000305	0.0033	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000305	0.0033	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000299	0.00323	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000299	0.00323	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000286	0.0031	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000284	0.00308	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000281	0.00304	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—CAV1—ovarian cancer	0.000272	0.00294	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.000264	0.00285	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	0.000263	0.00285	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00026	0.00282	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000256	0.00277	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000254	0.00274	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000251	0.00271	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP1B1—ovarian cancer	0.000249	0.00269	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PIK3CG—ovarian cancer	0.000248	0.00268	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000245	0.00265	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—TP53—ovarian cancer	0.000234	0.00253	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000233	0.00253	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000231	0.00249	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000228	0.00247	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000228	0.00247	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000228	0.00247	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PIK3CD—ovarian cancer	0.000218	0.00235	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000216	0.00233	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Neuronal System—MAPK1—ovarian cancer	0.000215	0.00232	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—IL6—ovarian cancer	0.000214	0.00232	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NME2—ovarian cancer	0.000204	0.0022	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000195	0.0021	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000195	0.0021	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000192	0.00208	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00019	0.00206	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PIK3CB—ovarian cancer	0.00019	0.00205	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000187	0.00203	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000185	0.002	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000183	0.00198	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IL2—ovarian cancer	0.000174	0.00189	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Neuronal System—HRAS—ovarian cancer	0.000172	0.00186	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000162	0.00175	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NME2—ovarian cancer	0.000161	0.00174	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.00016	0.00173	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000159	0.00172	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000156	0.00169	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NME2—ovarian cancer	0.000152	0.00164	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000149	0.00161	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—VEGFA—ovarian cancer	0.000148	0.0016	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—NRAS—ovarian cancer	0.000146	0.00158	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000146	0.00158	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000146	0.00157	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000146	0.00157	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—MAPK3—ovarian cancer	0.00014	0.00152	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000138	0.00149	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—MAPK1—ovarian cancer	0.000133	0.00144	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYTB—ovarian cancer	0.000131	0.00142	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000129	0.00139	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—KRAS—ovarian cancer	0.000126	0.00136	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000122	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000122	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000121	0.00131	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000117	0.00126	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PIK3CA—ovarian cancer	0.000116	0.00125	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPP1CC—ovarian cancer	0.000115	0.00124	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—BRIP1—ovarian cancer	0.000115	0.00124	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NME2—ovarian cancer	0.000114	0.00124	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TP53—ovarian cancer	0.000112	0.00121	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—HRAS—ovarian cancer	0.000107	0.00116	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000105	0.00113	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYTB—ovarian cancer	0.000104	0.00112	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYTB—ovarian cancer	9.78e-05	0.00106	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NME2—ovarian cancer	9.67e-05	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.56e-05	0.00103	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—AKT1—ovarian cancer	9.45e-05	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—BRIP1—ovarian cancer	9.06e-05	0.00098	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPP1CC—ovarian cancer	9.06e-05	0.00098	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—BRIP1—ovarian cancer	8.55e-05	0.000924	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPP1CC—ovarian cancer	8.55e-05	0.000924	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	8.21e-05	0.000888	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—YAP1—ovarian cancer	7.69e-05	0.000832	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NME2—ovarian cancer	7.47e-05	0.000808	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYTB—ovarian cancer	7.36e-05	0.000796	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.69e-05	0.000724	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPP1CC—ovarian cancer	6.43e-05	0.000696	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—BRIP1—ovarian cancer	6.43e-05	0.000696	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—FASN—ovarian cancer	6.27e-05	0.000678	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYTB—ovarian cancer	6.23e-05	0.000674	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.23e-05	0.000674	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—SLC5A5—ovarian cancer	6.17e-05	0.000667	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.09e-05	0.000659	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—YAP1—ovarian cancer	6.08e-05	0.000658	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—SLC2A1—ovarian cancer	5.96e-05	0.000644	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—YAP1—ovarian cancer	5.73e-05	0.00062	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP1B1—ovarian cancer	5.71e-05	0.000618	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.67e-05	0.000614	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPP1CC—ovarian cancer	5.45e-05	0.000589	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—BRIP1—ovarian cancer	5.45e-05	0.000589	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	5.07e-05	0.000548	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.99e-05	0.000539	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—FASN—ovarian cancer	4.96e-05	0.000536	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—SLC5A5—ovarian cancer	4.87e-05	0.000527	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYTB—ovarian cancer	4.81e-05	0.00052	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—SLC2A1—ovarian cancer	4.71e-05	0.000509	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ABCB1—ovarian cancer	4.7e-05	0.000509	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—FASN—ovarian cancer	4.67e-05	0.000505	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—TYMS—ovarian cancer	4.62e-05	0.0005	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SLC5A5—ovarian cancer	4.6e-05	0.000497	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP1B1—ovarian cancer	4.51e-05	0.000488	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SLC2A1—ovarian cancer	4.44e-05	0.00048	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.35e-05	0.00047	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—YAP1—ovarian cancer	4.31e-05	0.000467	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP1B1—ovarian cancer	4.26e-05	0.00046	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.2e-05	0.000455	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.2e-05	0.000455	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	4e-05	0.000433	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.97e-05	0.000429	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	3.77e-05	0.000408	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.76e-05	0.000406	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CAV1—ovarian cancer	3.72e-05	0.000403	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ABCB1—ovarian cancer	3.72e-05	0.000402	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—YAP1—ovarian cancer	3.65e-05	0.000395	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TYMS—ovarian cancer	3.65e-05	0.000395	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.62e-05	0.000391	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—FASN—ovarian cancer	3.52e-05	0.00038	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ABCB1—ovarian cancer	3.5e-05	0.000379	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC5A5—ovarian cancer	3.46e-05	0.000374	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TYMS—ovarian cancer	3.44e-05	0.000372	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CG—ovarian cancer	3.39e-05	0.000367	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC2A1—ovarian cancer	3.34e-05	0.000361	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1B1—ovarian cancer	3.2e-05	0.000346	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.18e-05	0.000344	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CD—ovarian cancer	2.98e-05	0.000322	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—FASN—ovarian cancer	2.98e-05	0.000322	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CAV1—ovarian cancer	2.94e-05	0.000318	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.93e-05	0.000317	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.84e-05	0.000307	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.83e-05	0.000306	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—YAP1—ovarian cancer	2.82e-05	0.000305	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CAV1—ovarian cancer	2.77e-05	0.0003	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.77e-05	0.0003	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.71e-05	0.000293	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CG—ovarian cancer	2.68e-05	0.00029	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.65e-05	0.000287	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ABCB1—ovarian cancer	2.64e-05	0.000285	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.6e-05	0.000281	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TYMS—ovarian cancer	2.59e-05	0.00028	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CG—ovarian cancer	2.53e-05	0.000273	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.41e-05	0.00026	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.39e-05	0.000259	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.36e-05	0.000255	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—FASN—ovarian cancer	2.3e-05	0.000249	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.26e-05	0.000245	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTEN—ovarian cancer	2.24e-05	0.000243	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.23e-05	0.000242	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CD—ovarian cancer	2.22e-05	0.00024	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TYMS—ovarian cancer	2.19e-05	0.000237	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.18e-05	0.000236	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.09e-05	0.000227	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CAV1—ovarian cancer	2.09e-05	0.000226	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.05e-05	0.000222	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CB—ovarian cancer	1.94e-05	0.000209	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.9e-05	0.000206	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.86e-05	0.000201	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTEN—ovarian cancer	1.77e-05	0.000192	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CAV1—ovarian cancer	1.77e-05	0.000191	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.72e-05	0.000187	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TYMS—ovarian cancer	1.69e-05	0.000183	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.69e-05	0.000183	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTEN—ovarian cancer	1.67e-05	0.000181	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.67e-05	0.000181	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.61e-05	0.000174	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.58e-05	0.000171	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.46e-05	0.000158	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.42e-05	0.000153	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CAV1—ovarian cancer	1.36e-05	0.000148	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKT1—ovarian cancer	1.29e-05	0.00014	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTEN—ovarian cancer	1.26e-05	0.000136	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.25e-05	0.000135	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.24e-05	0.000134	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.23e-05	0.000133	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.18e-05	0.000128	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.09e-05	0.000118	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTEN—ovarian cancer	1.07e-05	0.000115	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKT1—ovarian cancer	1.02e-05	0.000111	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKT1—ovarian cancer	9.64e-06	0.000104	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.52e-06	0.000103	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CA—ovarian cancer	8.88e-06	9.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTEN—ovarian cancer	8.23e-06	8.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CA—ovarian cancer	7.52e-06	8.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKT1—ovarian cancer	7.25e-06	7.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKT1—ovarian cancer	6.15e-06	6.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.81e-06	6.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKT1—ovarian cancer	4.74e-06	5.13e-05	CbGpPWpGaD
